News | Digital Pathology | June 14, 2019

Sectra Providing Centralized Regional Solution for Digital Pathology in the U.K.

Solution will improve cancer care workflow across 10 separate trusts of the U.K.’s Northern Cancer Alliance

Sectra Providing Centralized Regional Solution for Digital Pathology in the U.K.

June 14, 2019 – Sectra has signed a five-year contract with North Tees and Hartlepool National Health System (NHS) Foundation Trust for the delivery of a regional digital pathology solution to the Northern Cancer Alliance in the U.K. The solution will span the 10 separate trusts of the consortium, and aims to improve cancer care workflows through enabling pathologists to instantly access and share images and information between departments and locations.

“Digital pathology will be an enabler for collaborative working across large geographic areas, streamlining pathology diagnostic decision making, particularly for cancer diagnosis and multidisciplinary team meeting discussions. This represents the biggest and most exciting change to the way cellular pathologists work in a generation.” said Paul Barrett, M.D., histopathologist at County Durham and Darlington NHS Foundation Trust and co-clinical lead of the project.

Sonali Natu, M.D., histopathologist at North Tees and Hartlepool NHS Foundation Trust and the other co-clinical lead of the project, added, “As an integrated health and care system, we need to move away from isolation and head towards integration. This platform will deliver a large part of that ambition for the patients we serve. The digital access to pathology images and digital tools for reviewing them will in the end translate into easier collaboration, more resilient services and improved patient care.”

The solution will support 115 pathologists across the trusts, conducting an average of 300,000 examinations a year. Through Sectra’s central solution, they will be able to access all pathology images produced by the consortium and get one consolidated view of a patient record from a single interface.

Digital pathology will give the pathologists functionality beyond the microscope. Without the need for physical glass slides, digital access to current and historical images is enabled from anywhere and at any time. The digital solution provides pathologists with assistance at critical decision points, such as grading or doing more precise measurements. It also enables image analysis, which in turn reduces variation and improves the precision of tasks such as cell counting. The digital access further facilitates second opinions, external reading resources, specialist consultations and regional MDT case review meetings.

The trusts within the regional solution will be using picture archiving and communication system (PACS)-based reporting and integrate with multiple local laboratory information management systems (LIMS). This could, for example, facilitate workload balancing across the consortium and equal access to specialists for all patients in the region. The contract extension was signed during the fourth quarter of the fiscal year.

For more information: www.sectra.com

Related Content

Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
New Lung Ambition Alliance Aims to Double Five-year Lung Cancer Survival by 2025
News | Lung Cancer | July 17, 2019
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (...
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho
Fluke Biomedical Introduces RaySafe 452 Survey Meter
Technology | Radiation Dose Management | July 11, 2019
Radiation measurement often requires different devices for varying applications, adding to the cost and complexity of...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Videos | Enterprise Imaging | July 09, 2019
ITN Associate Editor Jeff Zagoudis speaks with Don Dennison